kf 17837s has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K; Jackson, MJ; Jenner, PG; Kanda, T; Kase, H; Koga, K; Kurokawa, M; Kuwana, Y; Ochi, M; Pearce, RK; Shiozaki, S; Smith, LA | 1 |
| Abe, K; Matsubara, E; Shoji, M | 1 |
2 review(s) available for kf 17837s and Parkinson Disease
| Article | Year |
|---|---|
Antiparkinsonian activity of adenosine A2A antagonists in experimental models.
Topics: Adenosine; Antiparkinson Agents; Humans; Motor Activity; Parkinson Disease; Phenethylamines; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Xanthines | 1999 |
[The treatment of Parkinson's disease--adenosine A2A receptor antagonists].
Topics: Antiparkinson Agents; Corpus Striatum; Dopamine; Drug Design; Humans; Parkinson Disease; Purinergic P1 Receptor Antagonists; Purines; Receptor, Adenosine A2A; Receptors, Purinergic P1; Xanthines | 2002 |